AnaMariaLopezMD

Oncology • Philadelphia, PA

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Complementary and Integrative

Physician

Join to view full profile

Dr. Lopez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lopez's full profile

Already have an account?

Office
925 Chestnut St
Ste 320A
Philadelphia, PA 19107
Phone+1 215-955-8874

Fax+1 215-955-2340

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1992 - 1995
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1988

Certifications & Licensure

AZ State Medical License 1990 - 2026
DE State Medical License 2018 - 2025
NJ State Medical License 2018 - 2025
PA State Medical License 2018 - 2024
UT State Medical License 2015 - 2020
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Community-Based Educational Intervention to Improve Colorectal Cancer Screening Start of enrollment: 2020 Jan 31
Recruiting
Roles: Principal Investigator, Contact
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer Start of enrollment: 2018 Nov 07
Active, not recruiting
Not Applicable
Roles: Contact
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer Start of enrollment: 2023 Nov 13
Recruiting
Not Applicable
Roles: Contact

Publications & Presentations

PubMed

34 citations
Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women.
Cynthia A. Thomson, Leslie Arendell, Roberta Bruhn, Gertraud Maskarinec, Ana Maria Lopez
Menopause. 2007-03-01
70 citations
Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Karen L. Margolis, Rebecca J. Rodabough, Cynthia A. Thomson, Ana Maria Lopez, Anne McTiernan
Archives of Internal Medicine. 2007-09-24
27 citations
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
Chun Wang, Zhaomei Mu, Zhong Ye, Zhenchao Zhang, Maysa M. Abu-Khalaf
Breast Cancer Research and Treatment. 2020-05-04